SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories
Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Mar 02, 17:00
3384.00
34.35 (1.03%)
VOLUME 11,317
LIVE
NSE
Mar 02, 17:00
3386.65
37.6 (1.12%)
VOLUME 272,219
Earnings News on Dr Reddys Laboratories
Select Year: 2013 |  2012 |  2011 | 2010 | 2009 | 2008 | 2007 | 2000-2006
Mixed Q3 nos for pharma so far: Here's what you should buy 

11.22 am | 13 Feb 2015 |  Source: CNBC-TV18

Hitesh Mahida is bullish on Cipla, Glenmark and Dr Reddy’s Laboratories from the large cap pharma space and suggests caution on Lupin for now. ...

Dr Reddys Labs consolidated Dec '14 sales at Rs 3,843.10 crore

9.52 am | 30 Jan 2015 |  Source: Moneycontrol.com

Dr Reddys Laboratories has reported a consolidated total income from operations of Rs 3,843.10 crore and a net profit of Rs 574.53 crore for the quart...

Russia's impact not fully played out in Q3: Dr Reddy's 

5.07 pm | 29 Jan 2015 |  Source: CNBC-TV18

Dr Reddy's Laboratories beat street expectations on both topline and bottomline but operating performance was below estimates. Consolidated net profit...

'DRL Q3 'good set of numbers'; Russia, North America +ve' 

2.59 pm | 29 Jan 2015 |  Source: CNBC-TV18

Discussing Dr Reddy’s third quarter earnings, Sarabjit Kaur Nangra told CNBC-TV18’s Ekta Batra and Sonia Shenoy the numbers were broadly in line b...

Dr Reddy's Q3 net falls 7% to Rs 575cr, OPM below estimates

1.34 pm | 29 Jan 2015 |  Source: Moneycontrol.com

Dr Reddy's Laboratories beat street expectations on topline and bottomline front but the operating performance was below estimates. Consolidated net p...

Dr Reddy's Labs Q3 profit seen down 14% to Rs 534 cr: Poll

4.12 pm | 28 Jan 2015 |  Source: Moneycontrol.com

Dr Reddy's Laboratories' third quarter profit is expected to fall 13.6 percent year-on-year to Rs 534.3 crore, according to the average of estimates o...

Likely to file 2 NDAs worth $100 m each soon: Dr Reddy's 

4.51 pm | 29 Oct 2014 |  Source: CNBC-TV18

Discussing the company’s results, GV Prasad co-chairman and CEO, DRL, said the quarter has been a flattish one on the back of high R&D expenses. He ...

Dr Reddy's Q2: Revenue hit by high expenditure, says expert 

1.21 pm | 29 Oct 2014 |  Source: CNBC-TV18

Dr Reddy's Laboratories reported a fall of 16.8 percent in its second quarter consolidated net profit to Rs 574 crore against Rs 690.2 crore in the ye...

Dr Reddy's Labs Q2 disappoints, net falls 17% to Rs 574 cr 

12.39 pm | 29 Oct 2014 |  Source: Moneycontrol.com

Consolidated operating profit during the quarter declined 12.2 percent year-on-year to Rs 646.5 crore and margin dropped 400 basis points to 18 percen...

US core business continues to be a drag for Ranbaxy: CIMB 

9.05 am | 29 Oct 2014 |  Source: CNBC-TV18

Prakash Agarwal, Equity Analyst, CIMB has a hold rating on Ranbaxy with target price of Rs 630/share. ...

Dr Reddy's Labs Q2 profit may fall 22% to Rs 537 cr: Poll

5.16 pm | 28 Oct 2014 |  Source: CNBC-TV18

Revenue is likely to increase 10.3 percent to Rs 3,702 crore in the quarter ended September 2014 compared to Rs 3,357 crore in same quarter last year ...

1
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.